The global market for NCI Digital Therapeutics was valued at US$ 929 million in the year 2024 and is projected to reach a revised size of US$ 1862 million by 2031, growing at a CAGR of 10.5% during the forecast period.

NCI Digital Therapeutics Market

NCI digital therapeutics refer to an innovative treatment approach for cognitive impairments caused by neurodegenerative diseases, particularly for Alzheimer's disease patients. Utilizing digital technologies such as virtual reality and artificial intelligence, it provides personalized cognitive rehabilitation training to enhance the quality of life for these patients. The necessity of NCI digital therapeutics lies in its ability to complement the shortcomings of traditional treatment methods, offering a more flexible and efficient rehabilitation solution. Its characteristic is the use of technological means to achieve precise treatment, focusing on individual differences and tailoring the therapy to each patient. The superiority of NCI digital therapeutic is reflected in its ability to overcome geographical barriers, reduce treatment costs, and increase patient engagement and therapeutic outcomes, bringing a new rehabilitation experience to Alzheimer's disease patients

North American market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for NCI Digital Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for NCI Digital Therapeutics in Medical Rehab Center is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of NCI Digital Therapeutics include MindMaze Labs, Akili, Cognoa, GrayMatters Health, Otsuka Pharmaceutical, TALi Health, Dario Health, Better Therapeutics, Nanjing Vishee Medical Technology, Zhejiang BrainAurora Medical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for NCI Digital Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NCI Digital Therapeutics.

The NCI Digital Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NCI Digital Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NCI Digital Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NCI Digital Therapeutics Market Report

Report Metric	Details
Report Name	NCI Digital Therapeutics Market
Accounted market size in year	US$ 929 million
Forecasted market size in 2031	US$ 1862 million
CAGR	10.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	AD AMCI
Segment by Application	Medical Rehab Center Hospitals Geriatric Facilities Nursing Homes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	MindMaze Labs, Akili, Cognoa, GrayMatters Health, Otsuka Pharmaceutical, TALi Health, Dario Health, Better Therapeutics, Nanjing Vishee Medical Technology, Zhejiang BrainAurora Medical Technology, Hunan Mental Health Medicine Technology, Hunan Aize Medical Technology, Qingdao Zhisong Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NCI Digital Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NCI Digital Therapeutics Market growing?

Ans: The NCI Digital Therapeutics Market witnessing a CAGR of 10.5% during the forecast period 2025-2031.

What is the NCI Digital Therapeutics Market size in 2031?

Ans: The NCI Digital Therapeutics Market size in 2031 will be US$ 1862 million.

Who are the main players in the NCI Digital Therapeutics Market report?

Ans: The main players in the NCI Digital Therapeutics Market are MindMaze Labs, Akili, Cognoa, GrayMatters Health, Otsuka Pharmaceutical, TALi Health, Dario Health, Better Therapeutics, Nanjing Vishee Medical Technology, Zhejiang BrainAurora Medical Technology, Hunan Mental Health Medicine Technology, Hunan Aize Medical Technology, Qingdao Zhisong Technology

What are the Application segmentation covered in the NCI Digital Therapeutics Market report?

Ans: The Applications covered in the NCI Digital Therapeutics Market report are Medical Rehab Center, Hospitals, Geriatric Facilities, Nursing Homes, Others

What are the Type segmentation covered in the NCI Digital Therapeutics Market report?

Ans: The Types covered in the NCI Digital Therapeutics Market report are AD, AMCI

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NCI Digital Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 AD

1.2.3 AMCI

1.3 Market by Application

1.3.1 Global NCI Digital Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Medical Rehab Center

1.3.3 Hospitals

1.3.4 Geriatric Facilities

1.3.5 Nursing Homes

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NCI Digital Therapeutics Market Perspective (2020-2031)

2.2 Global NCI Digital Therapeutics Growth Trends by Region

2.2.1 Global NCI Digital Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 NCI Digital Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 NCI Digital Therapeutics Market Dynamics

2.3.1 NCI Digital Therapeutics Industry Trends

2.3.2 NCI Digital Therapeutics Market Drivers

2.3.3 NCI Digital Therapeutics Market Challenges

2.3.4 NCI Digital Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NCI Digital Therapeutics Players by Revenue

3.1.1 Global Top NCI Digital Therapeutics Players by Revenue (2020-2025)

3.1.2 Global NCI Digital Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Top NCI Digital Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by NCI Digital Therapeutics Revenue

3.4 Global NCI Digital Therapeutics Market Concentration Ratio

3.4.1 Global NCI Digital Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NCI Digital Therapeutics Revenue in 2024

3.5 Global Key Players of NCI Digital Therapeutics Head office and Area Served

3.6 Global Key Players of NCI Digital Therapeutics, Product and Application

3.7 Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NCI Digital Therapeutics Breakdown Data by Type

4.1 Global NCI Digital Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031)

5 NCI Digital Therapeutics Breakdown Data by Application

5.1 Global NCI Digital Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America NCI Digital Therapeutics Market Size (2020-2031)

6.2 North America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America NCI Digital Therapeutics Market Size by Country (2020-2025)

6.4 North America NCI Digital Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NCI Digital Therapeutics Market Size (2020-2031)

7.2 Europe NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe NCI Digital Therapeutics Market Size by Country (2020-2025)

7.4 Europe NCI Digital Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NCI Digital Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific NCI Digital Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NCI Digital Therapeutics Market Size (2020-2031)

9.2 Latin America NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America NCI Digital Therapeutics Market Size by Country (2020-2025)

9.4 Latin America NCI Digital Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NCI Digital Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa NCI Digital Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 MindMaze Labs

11.1.1 MindMaze Labs Company Details

11.1.2 MindMaze Labs Business Overview

11.1.3 MindMaze Labs NCI Digital Therapeutics Introduction

11.1.4 MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025)

11.1.5 MindMaze Labs Recent Development

11.2 Akili

11.2.1 Akili Company Details

11.2.2 Akili Business Overview

11.2.3 Akili NCI Digital Therapeutics Introduction

11.2.4 Akili Revenue in NCI Digital Therapeutics Business (2020-2025)

11.2.5 Akili Recent Development

11.3 Cognoa

11.3.1 Cognoa Company Details

11.3.2 Cognoa Business Overview

11.3.3 Cognoa NCI Digital Therapeutics Introduction

11.3.4 Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025)

11.3.5 Cognoa Recent Development

11.4 GrayMatters Health

11.4.1 GrayMatters Health Company Details

11.4.2 GrayMatters Health Business Overview

11.4.3 GrayMatters Health NCI Digital Therapeutics Introduction

11.4.4 GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025)

11.4.5 GrayMatters Health Recent Development

11.5 Otsuka Pharmaceutical

11.5.1 Otsuka Pharmaceutical Company Details

11.5.2 Otsuka Pharmaceutical Business Overview

11.5.3 Otsuka Pharmaceutical NCI Digital Therapeutics Introduction

11.5.4 Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025)

11.5.5 Otsuka Pharmaceutical Recent Development

11.6 TALi Health

11.6.1 TALi Health Company Details

11.6.2 TALi Health Business Overview

11.6.3 TALi Health NCI Digital Therapeutics Introduction

11.6.4 TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025)

11.6.5 TALi Health Recent Development

11.7 Dario Health

11.7.1 Dario Health Company Details

11.7.2 Dario Health Business Overview

11.7.3 Dario Health NCI Digital Therapeutics Introduction

11.7.4 Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025)

11.7.5 Dario Health Recent Development

11.8 Better Therapeutics

11.8.1 Better Therapeutics Company Details

11.8.2 Better Therapeutics Business Overview

11.8.3 Better Therapeutics NCI Digital Therapeutics Introduction

11.8.4 Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025)

11.8.5 Better Therapeutics Recent Development

11.9 Nanjing Vishee Medical Technology

11.9.1 Nanjing Vishee Medical Technology Company Details

11.9.2 Nanjing Vishee Medical Technology Business Overview

11.9.3 Nanjing Vishee Medical Technology NCI Digital Therapeutics Introduction

11.9.4 Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)

11.9.5 Nanjing Vishee Medical Technology Recent Development

11.10 Zhejiang BrainAurora Medical Technology

11.10.1 Zhejiang BrainAurora Medical Technology Company Details

11.10.2 Zhejiang BrainAurora Medical Technology Business Overview

11.10.3 Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Introduction

11.10.4 Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)

11.10.5 Zhejiang BrainAurora Medical Technology Recent Development

11.11 Hunan Mental Health Medicine Technology

11.11.1 Hunan Mental Health Medicine Technology Company Details

11.11.2 Hunan Mental Health Medicine Technology Business Overview

11.11.3 Hunan Mental Health Medicine Technology NCI Digital Therapeutics Introduction

11.11.4 Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025)

11.11.5 Hunan Mental Health Medicine Technology Recent Development

11.12 Hunan Aize Medical Technology

11.12.1 Hunan Aize Medical Technology Company Details

11.12.2 Hunan Aize Medical Technology Business Overview

11.12.3 Hunan Aize Medical Technology NCI Digital Therapeutics Introduction

11.12.4 Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025)

11.12.5 Hunan Aize Medical Technology Recent Development

11.13 Qingdao Zhisong Technology

11.13.1 Qingdao Zhisong Technology Company Details

11.13.2 Qingdao Zhisong Technology Business Overview

11.13.3 Qingdao Zhisong Technology NCI Digital Therapeutics Introduction

11.13.4 Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025)

11.13.5 Qingdao Zhisong Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Otsuka Pharmaceutical

TALi Health

Dario Health

Better Therapeutics

Nanjing Vishee Medical Technology

Zhejiang BrainAurora Medical Technology

Hunan Mental Health Medicine Technology

Hunan Aize Medical Technology

Qingdao Zhisong Technology

List of Tables

Table 1. Global NCI Digital Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of AD

Table 3. Key Players of AMCI

Table 4. Global NCI Digital Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global NCI Digital Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global NCI Digital Therapeutics Market Share by Region (2020-2025)

Table 8. Global NCI Digital Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global NCI Digital Therapeutics Market Share by Region (2026-2031)

Table 10. NCI Digital Therapeutics Market Trends

Table 11. NCI Digital Therapeutics Market Drivers

Table 12. NCI Digital Therapeutics Market Challenges

Table 13. NCI Digital Therapeutics Market Restraints

Table 14. Global NCI Digital Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global NCI Digital Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top NCI Digital Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NCI Digital Therapeutics as of 2024)

Table 17. Ranking of Global Top NCI Digital Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by NCI Digital Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of NCI Digital Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of NCI Digital Therapeutics, Product and Application

Table 21. Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NCI Digital Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global NCI Digital Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global NCI Digital Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global NCI Digital Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global NCI Digital Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global NCI Digital Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific NCI Digital Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa NCI Digital Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. MindMaze Labs Company Details

Table 47. MindMaze Labs Business Overview

Table 48. MindMaze Labs NCI Digital Therapeutics Product

Table 49. MindMaze Labs Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 50. MindMaze Labs Recent Development

Table 51. Akili Company Details

Table 52. Akili Business Overview

Table 53. Akili NCI Digital Therapeutics Product

Table 54. Akili Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Akili Recent Development

Table 56. Cognoa Company Details

Table 57. Cognoa Business Overview

Table 58. Cognoa NCI Digital Therapeutics Product

Table 59. Cognoa Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Cognoa Recent Development

Table 61. GrayMatters Health Company Details

Table 62. GrayMatters Health Business Overview

Table 63. GrayMatters Health NCI Digital Therapeutics Product

Table 64. GrayMatters Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 65. GrayMatters Health Recent Development

Table 66. Otsuka Pharmaceutical Company Details

Table 67. Otsuka Pharmaceutical Business Overview

Table 68. Otsuka Pharmaceutical NCI Digital Therapeutics Product

Table 69. Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Otsuka Pharmaceutical Recent Development

Table 71. TALi Health Company Details

Table 72. TALi Health Business Overview

Table 73. TALi Health NCI Digital Therapeutics Product

Table 74. TALi Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 75. TALi Health Recent Development

Table 76. Dario Health Company Details

Table 77. Dario Health Business Overview

Table 78. Dario Health NCI Digital Therapeutics Product

Table 79. Dario Health Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Dario Health Recent Development

Table 81. Better Therapeutics Company Details

Table 82. Better Therapeutics Business Overview

Table 83. Better Therapeutics NCI Digital Therapeutics Product

Table 84. Better Therapeutics Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 85. Better Therapeutics Recent Development

Table 86. Nanjing Vishee Medical Technology Company Details

Table 87. Nanjing Vishee Medical Technology Business Overview

Table 88. Nanjing Vishee Medical Technology NCI Digital Therapeutics Product

Table 89. Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Nanjing Vishee Medical Technology Recent Development

Table 91. Zhejiang BrainAurora Medical Technology Company Details

Table 92. Zhejiang BrainAurora Medical Technology Business Overview

Table 93. Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Product

Table 94. Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Zhejiang BrainAurora Medical Technology Recent Development

Table 96. Hunan Mental Health Medicine Technology Company Details

Table 97. Hunan Mental Health Medicine Technology Business Overview

Table 98. Hunan Mental Health Medicine Technology NCI Digital Therapeutics Product

Table 99. Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Hunan Mental Health Medicine Technology Recent Development

Table 101. Hunan Aize Medical Technology Company Details

Table 102. Hunan Aize Medical Technology Business Overview

Table 103. Hunan Aize Medical Technology NCI Digital Therapeutics Product

Table 104. Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Hunan Aize Medical Technology Recent Development

Table 106. Qingdao Zhisong Technology Company Details

Table 107. Qingdao Zhisong Technology Business Overview

Table 108. Qingdao Zhisong Technology NCI Digital Therapeutics Product

Table 109. Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2020-2025) & (US$ Million)

Table 110. Qingdao Zhisong Technology Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. NCI Digital Therapeutics Picture

Figure 2. Global NCI Digital Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global NCI Digital Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. AD Features

Figure 5. AMCI Features

Figure 6. Global NCI Digital Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global NCI Digital Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Medical Rehab Center Case Studies

Figure 9. Hospitals Case Studies

Figure 10. Geriatric Facilities Case Studies

Figure 11. Nursing Homes Case Studies

Figure 12. Others Case Studies

Figure 13. NCI Digital Therapeutics Report Years Considered

Figure 14. Global NCI Digital Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global NCI Digital Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global NCI Digital Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global NCI Digital Therapeutics Market Share by Players in 2024

Figure 18. Global NCI Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by NCI Digital Therapeutics Revenue in 2024

Figure 20. North America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America NCI Digital Therapeutics Market Share by Country (2020-2031)

Figure 22. United States NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe NCI Digital Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific NCI Digital Therapeutics Market Share by Region (2020-2031)

Figure 34. China NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America NCI Digital Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa NCI Digital Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE NCI Digital Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. MindMaze Labs Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 50. Akili Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 51. Cognoa Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 52. GrayMatters Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 53. Otsuka Pharmaceutical Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 54. TALi Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 55. Dario Health Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 56. Better Therapeutics Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 57. Nanjing Vishee Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 58. Zhejiang BrainAurora Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 59. Hunan Mental Health Medicine Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 60. Hunan Aize Medical Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 61. Qingdao Zhisong Technology Revenue Growth Rate in NCI Digital Therapeutics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions